What Drugs Are Best for Bipolar Depression?

References

• Compton MT, Nemeroff CB: The treatment of bipolar depres-sion. J Clin Psychiatry 2000; 61:57–67
   PubMedGoogle Scholar
• Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott .1, Clayton PJ, Klerman GL, Hirschfeld RM: Differen-tial outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986; 255: 3138–3142
   Google Scholar
• Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V. Ascher JA, Earl NL, Greene PL, Monaghan ET: A double-blind, placebo-controlled, prophy-laxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61:841–850
   PubMedGoogle Scholar
• Akiskal HS: The prevalent clinical spectrum of bipolar disor-ders: Beyond DSM-IV. J Clin Psychopharmacol 1996; 16:4S–14S
   Google Scholar
• Thase ME, Sachs GS: Bipolar depression: Pharmacother-apy and related therapeutic strategies. Biol Psychiatry 2000; 48:558–572
   PubMed Web of Science ®Google Scholar
• Nolen WA, Bloemkolk D: Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm. Neuropsychobiology 2000; 42(Suppl 1):11–17
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Lenox MS, Baldessarini RJ: Effectiveness and safety of long-term antidepressant treatment in bipolar disor-der. J Clin Psychiatry 2001; 62:565–569
   PubMed Web of Science ®Google Scholar
• Sachs GS, Printz DJ. Kahn DA, Carpenter D, Docherty JP: The expert consensus guidelines series: Medication treatment of bipolar disorder 2000. Postgrad Med 2000; Special Issue:1–104
   Google Scholar
• Calabrese JR, Rapport DJ, Shelton MD, Kujawa NI. Kimmel SE: Clinical studies on the use of lamotrigine in bipolar disor-der. Neuropsychobiology 1998; 38:185–191
   Google Scholar
• Cohn JB, Collins G, Ashbrook E, Wernicke JF: A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989: 4:313–322
   PubMed Web of Science ®Google Scholar
• Young LT, Joffe RT, Robb IC, MacQueen GM, Marriott NI, Patelis-Siotis I: Double-blind comparison of addition of a sec-ond mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124–126
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Evans DL, Gyulai L. Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158:906–912
   Google Scholar
• Silverstone T: Moclobemide vs. imipramine in bipolar depres-sion: A multicentre double-blind clinical trial. Acta Psychiatr Scand 2001; 104:104–109
   Google Scholar
• Wehr TA, Goodwin FK: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403–1411
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L: Antidepressant-induced mania and cycle ac-celeration: A controversy revisited. Am J Psychiatry 1995; 152:1130–1138
   PubMed Web of Science ®Google Scholar
• Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum IF: A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994; 55:391–393
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, McElroy SL, Cookson J, Andersen J, Keck PE, Jr., Rhodes L. Bolden-Watson C, Zhou J, Ascher JA: Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 1999; 156:1019–1023
   Google Scholar
• Peet M: Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164:549–550
   PubMed Web of Science ®Google Scholar
• Bauer M, Zaninelli R, Muller-Oerlinghausen B, Meister W: Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: A double-blind study. J Clin Psychopharmacol 1999; 19:164–171
   PubMed Web of Science ®Google Scholar
• Amsterdam JD, Garcia-Espana F: Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affect Disord 2000; 59:225–229
   PubMed Web of Science ®Google Scholar
• Vieta E, Martinez-Aran A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M: A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar de-pressed patients taking mood stabilizers. J Clin Psychiatry 2002; 63:508–512
   PubMed Web of Science ®Google Scholar
• Shopsin B: Bupropion's prophylactic efficacy in bipolar affec-tive illness. J Clin Psychiatry 1983; 44:163–169
   PubMedGoogle Scholar
• Haykal RF, Akiskal HS: Bupropion as a promising approach to rapid cycling bipolar II patients. J Clin Psychiatry 1990; 51:450–455
   PubMed Web of Science ®Google Scholar
• Himmelhoch JM, Thase ME, Mallinger AG, Houck P: Tranyl-cypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148:910–916
   PubMed Web of Science ®Google Scholar
• Ketter TA, Calabrese JR: Stabilization of mood from below versus above baseline in bipolar disorder: A new nomencla-ture. J Clin Psychiatry 2002:63:146–151
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Rapport DJ: Mood stabilizers and the evolu-tion of maintenance study designs in bipolar I disorder. J Clin Psychiatry 1999; 60:5–13
   Google Scholar
• Zornberg GL, Pope HG, Jr.: Treatment of depression in bipo-lar disorder: New directions for research. J Clin Psychophar-macol 1993; 13:397–408
   Google Scholar
• Strakowski SM, McElroy SL, Keck PE: Clinical efficacy of valproate in bipolar illness: Comparisons and contrasts with lithium. In: Halbreich U, Montgomery SA, eds. Pharmacother-apy for Mood, Anxiety, and Cognitive Disorders, Washington, DC: American Psychiatric Press; 2000:143–157
   Google Scholar
• Goodwin FK, Jamison KR: Manic-Depressive Illness. New York: Oxford University Press; 1990
   Google Scholar
• Goodwin FK, Murphy DL, Bunney WE, Jr.: Lithium-carbonate treatment in depression and mania. A longitudi-nal double-blind study. Arch Gen Psychiatry 1969; 21:486–496
   Google Scholar
• Goodwin FK, Murphy DL, Dunner DL, Bunney WE. Jr.: Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972; 129:44 17
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J: Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999; 60(Suppl 2):77–84
   PubMedGoogle Scholar
• McElroy SL, Keck PE, Jr., Pope HG Jr., Hudson JI: Valproate in psychiatric disorders: Literature review and clinical guide-lines. J Clin Psychiatry 1989; 50(Suppl):23–29
   Google Scholar
• Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC: A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149:108–111
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck PE, Jr., Pope HG, Jr., Hudson JI: Valproate in primary psychiatric disorders: Literature review and clinical experience in a private psychiatric hospital. In: McElroy SL, Pope HG, Jr., eds. Use of Anticonvulsants in Psychiatry: Re-cent Advances. Clifton, NJ: Oxford Health Care; 1988:25–41
   Google Scholar
• Lambert PA: Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Muller AA, eds. Anticonvulsants in Affective Disorders. Amsterdam: Elsevier Science; 1984:33–44
   Google Scholar
• Calabrese JR, Delucchi GA: Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psy-chiatry 1990; 147:431–434
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC: Spec-trum of efficacy of valproate in 78 rapid-cycling bipolar pa-tients. J Clin Psychopharmacol 1992; 12:53S–56S
   Google Scholar
• Post RM, Uhde TW, Roy-Byrne PP, Joffe RT: Antidepressant effects of carbamazepine. Am J Psychiatry 1986; 143:29–34
   PubMed Web of Science ®Google Scholar
• Denicoff KID, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM: Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58:470–478
   PubMed Web of Science ®Google Scholar
• Greil W, Kleindienst N: The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disor-der. Int Clin Psychopharmacol 1999; 14:277–281
   PubMedGoogle Scholar
• Bowden CL, Mitchell P. Suppes T: Lamotrigine in the treat-ment of bipolar depression. Eur Neuropsychopharmacol 1999; 9(Suppl 4):S113–S117
   Google Scholar
• Calabrese JR, Fatemi SH, Woyshville NtJ: Antidepressant ef-fects of lamotrigine in rapid cycling bipolar disorder [letter], Am J Psychiatry 1996; 153:1236
   PubMed Web of Science ®Google Scholar
• Kusumakar V. Yatham LN: An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997; 72:145–148
   PubMed Web of Science ®Google Scholar
• Sporn J, Sachs G: The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997; 17:185–189
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD: A double-blind placebo-controlled study of lam-otrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60:79–88
   PubMed Web of Science ®Google Scholar
• Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Locatelli G, Leverich GS, Post RM: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607–614
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, Sachs O, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hy-pomanic patients with bipolar 1 disorder. Arch Gen Psychiatry 2003; 60:392–400
   PubMed Web of Science ®Google Scholar
• Pande AC, Crockatt JO, Janney CA, Werth JL, Tsaroucha G: Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2:249–255
   PubMed Web of Science ®Google Scholar
• McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen I, Leverich GS, Post RM: Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000; 47:1025–1033
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159:1–50
   Web of Science ®Google Scholar
• Davis JM, Janicak PG, Hogan DM: Mood stabilizers in the prevention of recurrent affective disorders: A meta-analysis. Acta Psychiatr Scand 1999; 100:406–417
   PubMed Web of Science ®Google Scholar
• Zerjav-Lacombe S. Tabarsi E: Lamotrigine: A review of clini-cal studies in bipolar disorders. Can J Psychiatry 2001; 46:328–333
   Google Scholar
• Walden J, Hesslinger B, van Calker D, Berger M: Addition of lamotrigine to valproate may enhance efficacy in the treat-ment of bipolar affective disorder. Pharmacopsychiatry 1996; 29:193–195
   PubMed Web of Science ®Google Scholar
• Potter WZ: Bipolar depression: Specific treatments. I Clin Psy-chiatry 1998; 59(Suppl 18):30–36
   Google Scholar
• Brodie MJ, Yuen AW: Lamotrigine substitution study: Evi-dence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 1997; 26:423–432
   PubMed Web of Science ®Google Scholar
• Lamictal product information: Presented at the Based on: Physicians' Desk Reference, 56th edn. 2002
   Google Scholar
• Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL: The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry 1998; 59(Suppl 4):73–79
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Rapport DJ, Calabrese JR, Thuras P: Lamotrig-ine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997; 58:522–527
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, Rhodes U, Keck PE, Jr.. Cookson J, Anderson I, Bolden-Watson C, Ascher 1, Monaghan E, Zhou J: The efficacy of lamotrigine in rapid cy-cling and non-rapid cycling patients with bipolar disorder. Blot Psychiatry 1999; 45:953–958
   PubMed Web of Science ®Google Scholar